| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,626 |
5,861 |
$53K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
3,273 |
2,984 |
$39K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,905 |
1,724 |
$18K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,774 |
2,355 |
$14K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,329 |
1,326 |
$13K |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
3,861 |
3,496 |
$9K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
445 |
444 |
$6K |
| H0001 |
Alcohol and/or drug assessment |
4,655 |
4,263 |
$5K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
370 |
333 |
$5K |
| 99401 |
|
1,435 |
1,369 |
$5K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
3,949 |
3,634 |
$4K |
| 99442 |
|
630 |
609 |
$4K |
| 3074F |
|
3,413 |
3,094 |
$4K |
| 96160 |
|
185 |
183 |
$4K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
228 |
221 |
$4K |
| 93000 |
|
198 |
197 |
$3K |
| 3078F |
|
2,769 |
2,534 |
$3K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
3,754 |
3,352 |
$2K |
| 3079F |
|
1,589 |
1,494 |
$2K |
| 0011A |
|
41 |
41 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
2,341 |
2,311 |
$1K |
| 87110 |
|
76 |
76 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
97 |
95 |
$891.57 |
| 0012A |
|
24 |
24 |
$804.43 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23 |
23 |
$773.68 |
| 86580 |
|
101 |
89 |
$752.85 |
| 1111F |
|
200 |
186 |
$544.07 |
| 90756 |
|
45 |
45 |
$378.00 |
| 3075F |
|
300 |
284 |
$355.50 |
| 1126F |
|
3,094 |
2,826 |
$333.00 |
| 1159F |
|
4,344 |
3,813 |
$275.00 |
| 90658 |
|
45 |
45 |
$235.94 |
| 1160F |
|
4,950 |
4,268 |
$215.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
96 |
85 |
$154.53 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
28 |
28 |
$113.02 |
| 99408 |
|
57 |
52 |
$108.35 |
| 94760 |
|
270 |
245 |
$99.88 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
360 |
330 |
$96.00 |
| 3077F |
|
103 |
93 |
$45.00 |
| 3050F |
|
599 |
572 |
$40.00 |
| G2010 |
Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment |
598 |
593 |
$35.29 |
| 1125F |
|
209 |
201 |
$8.00 |
| 0556F |
|
1,799 |
1,691 |
$0.76 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
4,158 |
3,823 |
$0.76 |
| 3011F |
|
1,802 |
1,693 |
$0.76 |
| 4010F |
|
603 |
540 |
$0.01 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
1,895 |
1,726 |
$0.01 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,348 |
1,231 |
$0.00 |
| G9507 |
Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) |
1,202 |
1,110 |
$0.00 |
| 3016F |
|
3,366 |
3,098 |
$0.00 |
| G9150 |
National committee for quality assurance - level 3 medical home |
5,709 |
5,113 |
$0.00 |
| 4013F |
|
894 |
827 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
337 |
306 |
$0.00 |
| G8506 |
Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
310 |
278 |
$0.00 |
| 3725F |
|
3,854 |
3,509 |
$0.00 |
| G9820 |
Documentation of a chlamydia screening test with proper follow-up |
141 |
123 |
$0.00 |
| G8935 |
Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
690 |
617 |
$0.00 |
| 0518F |
|
34 |
30 |
$0.00 |
| G8399 |
Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed |
41 |
38 |
$0.00 |
| 1003F |
|
34 |
30 |
$0.00 |
| 1033F |
|
52 |
47 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
21 |
20 |
$0.00 |
| 1090F |
|
34 |
30 |
$0.00 |
| 3095F |
|
43 |
40 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
32 |
31 |
$0.00 |
| 3288F |
|
34 |
30 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
58 |
54 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
74 |
66 |
$0.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
15 |
14 |
$0.00 |
| 1036F |
|
3,395 |
3,115 |
$0.00 |
| 1000F |
|
3,590 |
3,286 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
1,115 |
1,026 |
$0.00 |
| 3017F |
|
1,011 |
902 |
$0.00 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
3,519 |
3,150 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
2,594 |
2,339 |
$0.00 |
| 4086F |
|
456 |
413 |
$0.00 |
| 1220F |
|
57 |
51 |
$0.00 |
| 3014F |
|
941 |
866 |
$0.00 |
| 3008F |
|
4,518 |
4,049 |
$0.00 |
| 99422 |
|
43 |
42 |
$0.00 |
| 2000F |
|
62 |
56 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
225 |
205 |
$0.00 |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
402 |
357 |
$0.00 |
| 3049F |
|
130 |
123 |
$0.00 |
| G8734 |
Elder maltreatment screen documented as negative, follow-up is not required |
54 |
49 |
$0.00 |
| 3048F |
|
175 |
170 |
$0.00 |
| 91301 |
|
63 |
61 |
$0.00 |
| 97802 |
|
70 |
65 |
$0.00 |
| 2010F |
|
376 |
336 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
136 |
122 |
$0.00 |
| G8473 |
Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed |
36 |
32 |
$0.00 |
| 2001F |
|
62 |
56 |
$0.00 |
| 4008F |
|
107 |
100 |
$0.00 |
| 1170F |
|
48 |
43 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
63 |
56 |
$0.00 |
| 1101F |
|
34 |
30 |
$0.00 |
| 3044F |
|
15 |
14 |
$0.00 |